ContraFect Announces Presentation of New Data from its Amurin Peptide Program at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance August 28, 2019 - NASDAQ Companies 0 » View More News for August 28, 2019